GO Term | Evidence Code | PMID |
---|---|---|
muscle cell cellular homeostasis | ||
protein O-linked glycosylation | ||
protein O-linked mannosylation |
GO Term | Evidence Code | PMID |
---|---|---|
Golgi apparatus | ||
Golgi membrane |
GO Term | Evidence Code | PMID |
---|---|---|
UDP-xylosyltransferase activity | ||
manganese ion binding | ||
protein binding | ||
xylosyltransferase activity | ||
glucuronosyltransferase activity |
Species | Protein | mRNA |
---|---|---|
Rattus norvegicus | NP_954538 | NM_199107 |
Mus musculus | NP_766258 | NM_172670 |
DO ID | Disease Name | Source |
---|---|---|
DOID:0110278 | autosomal recessive limb-girdle muscular dystrophy type 2D | |
DOID:0110279 | autosomal recessive limb-girdle muscular dystrophy type 2E | |
DOID:0110280 | autosomal recessive limb-girdle muscular dystrophy type 2F | |
DOID:0110281 | autosomal recessive limb-girdle muscular dystrophy type 2G | |
DOID:0110282 | autosomal recessive limb-girdle muscular dystrophy type 2H | |
DOID:0110283 | autosomal recessive limb-girdle muscular dystrophy type 2J | |
DOID:0110284 | autosomal recessive limb-girdle muscular dystrophy type 2L | |
DOID:0110285 | autosomal recessive limb-girdle muscular dystrophy type 2Q | |
DOID:0110286 | obsolete autosomal recessive limb-girdle muscular dystrophy type 2R | |
DOID:0110287 | autosomal recessive limb-girdle muscular dystrophy type 2S |
Species | Gene ID | Alliance of Genome Resources | Orthologous MAtrix |
---|---|---|---|
187206 | WB:WBGene00010716 | ||
446214 | ZFIN:ZDB-GENE-050419-253 | ||
398936 | Xenbase:XB-GENE-5872007 | ||
734944 | Xenbase:XB-GENE-6256639 | ||
100125087 | Xenbase:XB-GENE-5871953 | ||
100414072 | CALJA03721 | ||
105592790 | CERAT37864 | ||
102144935 | MACFA09112 | ||
105471652 | MACNE14400 | ||
101010541 | PAPAN05200 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.0.0
Last updated: August 19, 2024